BUY Hindalco Industries Ltd. — Rajesh Satpute
byRajesh SatputeHorizon: NA (inferred Swing (≤2wk))4 Nov 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Novelis Q2 Review: Hindalco's Subsidiary Posts 29% Profit Growth; Brokerages Split
NewsNdtv-Profit·6 Nov · today
Novelis Inc., a wholly owned subsidiary of Hindalco, reported Q2 FY27 net income of $210 million, up 29% YoY, and Adjusted EBITDA of $508 million, up 20% YoY.
BSE · Company Update·5 Nov · today
Hindalco's subsidiary, Novelis Inc., reported Q2 FY2027 results with net income of $210 million (up 29% YoY) and Adjusted EBITDA of $508 million (up 20% YoY).
NSE · Press Release·5 Nov · today
Accumulate aluminium stocks on dips; Hindalco remains top pick: Motilal Oswal's Siddhartha Khemka
NewsCnbc-Tv18·23 Oct · 2w ago
Vedanta Aluminium shares can jump 40%; Nomura recommends buying its peer as well
NewsCnbc-Tv18·22 Oct · 2w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Hindalco Industries
- BUY — Morgan Stanley6 Nov 2026 · ~1 year · target ₹1,140 · Active
- BUY — Rachna Vaidya4 Nov 2026 · Same day · target ₹925 · Target hit
- BUY — Chandan Taparia, Motilal Oswal3 Nov 2026 · ~2 weeks · target ₹940 · Target hit
- BUY — Arun Kumar Mantri3 Nov 2026 · Same day · target ₹929 · Expired
- BUY — Prakash Gaba2 Nov 2026 · ~2 weeks · target ₹922 · Target hit
More from Rajesh Satpute
- BUY Zensar Technologies6 Nov 2026 · ~2 weeks · target ₹610 · Active
- BUY Karur Vysya Bank6 Nov 2026 · Same day · target ₹370 · Target hit
- BUY SBI Life Insurance Company5 Nov 2026 · Same day · target ₹1,760 · Expired
- BUY One 97 Communications5 Nov 2026 · ~2 weeks · target ₹1,850 · Active
- BUY Mankind Pharma5 Nov 2026 · Same day · target ₹2,600 · SL hit

